Argentina vs Colombia: HIV-positive TB patients on ART (antiretroviral therapy)
Argentina
69.0%
in 2024
Colombia
68.0%
in 2024
Argentina rank
128th
Colombia rank
130th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Argentina
- Colombia
How they compare
Argentina currently reports 69.0% against 68.0% in Colombia, a difference of 1.0%.
The two have swapped places 1 time across 9 shared years of data; in 2016 it was Colombia ahead.
Argentina ranks 128th and Colombia ranks 130th of 144 countries.
Across the 2 decades both report, Argentina averaged higher in 1 and Colombia in 1.
Head to head by decade
| Decade | Argentina | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 19.2% | 59.8% | 40.6% | Colombia |
| 2020s | 76.2% | 59.8% | 16.4% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Argentina or Colombia?
- Argentina, at 69.0% against 68.0% in Colombia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Argentina and Colombia?
- 1.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Colombia?
- 9 years are reported by both, from 2016 to 2024.
- How do Argentina and Colombia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Argentina ranks 128th and Colombia ranks 130th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.